Status:

RECRUITING

Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.

Lead Sponsor:

Institut Curie

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

This study will compare morphine consumption during the first 48 hours postoperatively between the OFA group and the CA control group.

Eligibility Criteria

Inclusion

  • Women aged 18 or older.
  • Patients with a French health insurance coverage (having a French social security number).
  • Patient eligible for free flap reconstruction surgery of the breastunder general anaesthesia.
  • Patient who has given written consent to participate in accordance with the regulations.
  • Having a negative blood pregnancy test for patients of childbea ring age.

Exclusion

  • Allergy or intolerance to any of the drugs (dexmedetomidine, remifentanil, lidocaine, propofol, dexamethasone, kétamine, ketoprofen, nefopam, paracetamol, morphine, ropivacaine, droperidol, ondansetron).
  • Known history of heart failure, arrhythmias and/or ischemic heart disease and/or severe renal insufficiency.
  • Pulse below 50bpm during anaesthesia consultation and/or under beta blocker treatment.
  • Treatment with ACEI/ARB.
  • Severe asthma.
  • Symptomatic gastric or duodenal ulcer with or without treatment.
  • Baseline systolic blood pressure \< 100 mmHg.
  • Chronic preoperative pain and/or use of WHO ladder step 2 or 3 analgesics preoperatively.
  • Patient already included in another therapeutic trial evaluating an experimental molecule.
  • Persons deprived of liberty or under guardianship.
  • Patients with suspected difficulties in assessing pain on a scale.
  • Inability to undergo trial medical monitoring due to geographic, social or psychological reasons.

Key Trial Info

Start Date :

December 7 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 15 2026

Estimated Enrollment :

158 Patients enrolled

Trial Details

Trial ID

NCT05439005

Start Date

December 7 2022

End Date

March 15 2026

Last Update

September 19 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Institut Curie Paris

Paris, France, 75005

2

Institut Curie Saint-Cloud

Saint-Cloud, France, 92210

3

Gustave Roussy, Cancer Campus, Grand Paris

Villejuif, France